🇺🇸 FDA
Patent

US 9695223

Engineered xylose transporters with reduced glucose inhibition

granted A61KA61K38/00

Quick answer

US patent 9695223 (Engineered xylose transporters with reduced glucose inhibition) held by The Board of Regents of the University of Texas System expires Mon Jun 29 2037 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Board of Regents of the University of Texas System
Grant date
Tue Jul 04 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jun 29 2037 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
9
CPC classes
A61K, A61K38/00